New MRI technique aims to see lung Cancer's immune profile without surgery
NCT ID NCT07486219
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether advanced MRI scans can identify different immune types of non-small cell lung cancer (NSCLC) without needing a tissue biopsy. Researchers will scan 50 adults with early-stage lung cancer and compare MRI results to standard lab tests. If successful, this approach could help doctors choose treatments faster and less invasively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Family support may be key to easing lung cancer surgery stress
- Can a drop of blood predict disease years before it strikes?
- Blood, urine, and stool may hold the key to predicting a serious side effect of lung cancer treatment
- Microwave ablation vs. radiotherapy: which Non-Surgical option works best for early lung cancer?
- Double-Targeted therapy aims to outsmart Hard-to-Treat lung cancer